Oncobiologics Inc

OVERVIEW Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Our current focus is on technically challenging and commercially attractive monoclonal antibodies (mAbs), in the disease areas of immunology and oncology. Our strategy is to cost-effectively develop these biosimilars on an accelerated timeline, which is fundamental to our success and we believe positions us to be a leading biosimilar company. We have leveraged our teams biopharmaceutical expertise to establish fully integrated in-house development and manufacturing capabilities, which we refer to as our BioSymphonyTM Platform. Oncobiologics platform addresses the numerous complex technical and...

Oncology,immunology,monoclonal antibodies,and biosimilars

Oncobiologics inc operates in the Biotechnology research industry.

Oncobiologics inc's revenue is 11m - 100m

Oncobiologics inc has 11 - 50 employees.